In immunocompetent patients, clearing CCR1-presenting BL cells by immune cells may be one of the mechanisms underlying in vivo selection of BL cells with EBV-restricted latencies (EBNA1 only, EBNA2-deleted, EBNA2+/LMP1-deleted). Here, CCR1 is linked to Burkitt lymphoma.